W Häuser1,2, M Nothacker3. 1. Innere Medizin I (Gastroenterologie, Hepatologie, Stoffwechsel- und Infektionskrankheiten, Psychosomatik), Klinikum Saarbrücken gGmbH, Winterberg 1, 66119, Saarbrücken, Deutschland. whaeuser@klinikum-saarbruecken.de. 2. Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Technische Universität München, München, Deutschland. whaeuser@klinikum-saarbruecken.de. 3. AWMF-Institut für Medizinisches Wissensmanagement, Philipps-Universität, Marburg, Deutschland.
Abstract
BACKGROUND: The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was planned for April 2017. METHODS: The guidelines were developed by 13 scientific societies and 2 patient self-help organizations coordinated by the German Pain Society. Working groups (n = 8) with a total of 42 members were formed balanced with respect to gender, medical expertise, position in the medical or scientific hierarchy and potential conflicts of interest. RESULTS: A systematic search of the literature from December 2010 to May 2016 was performed in the Cochrane library, MEDLINE, PsycINFO and Scopus databases. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine version 2009. The strength of recommendations was achieved by multiple step formalized procedures to reach a consensus. Efficacy, risks, patient preferences and applicability of therapies available were weighed up against each other. The guidelines were reviewed and approved by the board of directors of the societies engaged in the development of the guidelines. CONCLUSION: The guidelines are published in several forms, i.e. complete and short scientific versions and clinical practice and patient versions.
BACKGROUND: The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was planned for April 2017. METHODS: The guidelines were developed by 13 scientific societies and 2 patient self-help organizations coordinated by the German Pain Society. Working groups (n = 8) with a total of 42 members were formed balanced with respect to gender, medical expertise, position in the medical or scientific hierarchy and potential conflicts of interest. RESULTS: A systematic search of the literature from December 2010 to May 2016 was performed in the Cochrane library, MEDLINE, PsycINFO and Scopus databases. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine version 2009. The strength of recommendations was achieved by multiple step formalized procedures to reach a consensus. Efficacy, risks, patient preferences and applicability of therapies available were weighed up against each other. The guidelines were reviewed and approved by the board of directors of the societies engaged in the development of the guidelines. CONCLUSION: The guidelines are published in several forms, i.e. complete and short scientific versions and clinical practice and patient versions.
Entities:
Keywords:
Association of the Scientific Medical Societies in Germany; Fibromyalgia syndrome; German Pain Society; Guidelines; Methodology
Authors: Jacob N Ablin; Howard Amital; Michael Ehrenfeld; Valerie Aloush; Ori Elkayam; Pnina Langevitz; Dror Mevorach; Reuven Mader; Tali Sachar; Daniela Amital; Dan Buskila Journal: Harefuah Date: 2013-12
Authors: Mary-Ann Fitzcharles; Peter A Ste-Marie; Don L Goldenberg; John X Pereira; Susan Abbey; Manon Choinière; Gordon Ko; Dwight E Moulin; Pantelis Panopalis; Johanne Proulx; Yoram Shir Journal: Pain Res Manag Date: 2013 May-Jun Impact factor: 3.037
Authors: Martin Härter; C Klesse; I Bermejo; M Lelgemann; S Weinbrenner; G Ollenschläger; I Kopp; M Berger Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Date: 2008-04 Impact factor: 1.513
Authors: Philip Mease; Lesley M Arnold; Ernest H Choy; Daniel J Clauw; Leslie J Crofford; Jennifer M Glass; Susan A Martin; Jessica Morea; Lee Simon; C Vibeke Strand; David A Williams Journal: J Rheumatol Date: 2009-10 Impact factor: 4.666
Authors: W Eich; K-J Bär; M Bernateck; M Burgmer; C Dexl; F Petzke; C Sommer; A Winkelmann; W Häuser Journal: Schmerz Date: 2017-06 Impact factor: 1.107
Authors: A Winkelmann; H Bork; W Brückle; C Dexl; P Heldmann; P Henningsen; L Krumbein; V Pullwitt; M Schiltenwolf; W Häuser Journal: Schmerz Date: 2017-06 Impact factor: 1.107
Authors: V Köllner; K Bernardy; W Greiner; L Krumbein; H Lucius; M Offenbächer; M Sarholz; M Settan; W Häuser Journal: Schmerz Date: 2017-06 Impact factor: 1.107
Authors: F Petzke; W Brückle; U Eidmann; P Heldmann; V Köllner; T Kühn; H Kühn-Becker; M Strunk-Richter; M Schiltenwolf; M Settan; M von Wachter; M Weigl; W Häuser Journal: Schmerz Date: 2017-06 Impact factor: 1.107
Authors: J Langhorst; P Heldmann; P Henningsen; K Kopke; L Krumbein; H Lucius; A Winkelmann; B Wolf; W Häuser Journal: Schmerz Date: 2017-06 Impact factor: 1.107
Authors: M Schiltenwolf; U Eidmann; V Köllner; T Kühn; M Offenbächer; F Petzke; M Sarholz; M Weigl; B Wolf; W Häuser Journal: Schmerz Date: 2017-06 Impact factor: 1.107
Authors: N Üçeyler; M Burgmer; E Friedel; W Greiner; F Petzke; M Sarholz; M Schiltenwolf; A Winkelmann; C Sommer; W Häuser Journal: Schmerz Date: 2017-06 Impact factor: 1.107
Authors: C Sommer; R Alten; K-J Bär; M Bernateck; W Brückle; E Friedel; P Henningsen; F Petzke; T Tölle; N Üçeyler; A Winkelmann; W Häuser Journal: Schmerz Date: 2017-06 Impact factor: 1.107